Medical Bulletin 26/September/2026 Written By Anshika Mishra26 Sept 2026 3:00 PM ISTHere are the top medical news for today: Psoriasis Treatments Linked to Varying Risks of Infection, Study FindsTuberculosis and meningitis were rare...
Psoriasis Treatments Linked to Varying Risks of Infection, Study Finds Written By Anshika Mishra26 Sept 2026 8:00 AM ISTTuberculosis and meningitis were rare among people receiving systemic treatments for psoriasis, while candidiasis was more common among those treated...
Calcipotriol/betamethasone Cream: Effective and Well-Tolerated Psoriasis Treatment Written By Dr. Shravani Dali21 Sept 2026 8:15 PM ISTAccording to a new study, Calcipotriol/betamethasone cream is a safe and effective treatment for psoriasis across various clinical presentations. Its...
Lupin Recalls Clobetasol Propionate Cream Batch in US After Content Uniformity Failure Written By Parthika Patel4 Sept 2026 9:39 PM ISTMumbai: Lupin Limited is carrying out a voluntary recall of 5,082 tubes of clobetasol propionate cream in the United States after the product failed...
Psoriasis Linked to Higher Risk of Acute Periodontal Abscesses: Study Written By Dr Riya Dave17 Aug 2026 8:45 PM ISTResearchers have found in a new study that Psoriasis is independently associated with an increased risk of acute periodontal abscesses, even after...
GLP-1 Receptor Agonists May Improve Psoriasis Severity and Inflammation: JAMA Written By Medha Baranwal27 July 2026 8:00 PM ISTUSA: A review published in JAMA Dermatology suggests that GLP-1 receptor agonists may offer potential benefits as an adjunctive treatment for selected...
Six weeks of secukinumab reduces hidden tendon inflammation in psoriasis patients, ultrasound reveals Written By Dr. Kamal Kant Kohli23 July 2026 9:00 PM ISTBefore joints become painful, psoriatic arthritis (PsA) often begins silently as enthesitis-inflammation where tendons and ligaments attach to bone....
FDA Approves Risankizumab (Skyrizi) for Pediatric Plaque Psoriasis and Psoriatic Arthritis Written By Dr. Kamal Kant Kohli30 Jun 2026 8:30 PM ISTThe U.S. Food and Drug Administration has expanded the approved indications for Skyrizi to include the treatment of pediatric patients aged 6 years...
New study hints at the cause of a painful skin condition-and at a long-awaited potential treatment Written By Dr. Kamal Kant Kohli26 Jun 2026 8:30 PM ISTImagine a skin condition so painful, people with it are reduced to crawling around their homes to avoid having to walk on thick and painful calluses....
Can diabetes and obesity drugs also help the skin? Written By Dr. Kamal Kant Kohli23 Jun 2026 9:15 PM ISTGLP-1 receptor agonists are currently among the most widely discussed classes of drugs worldwide. They have gained popularity for their effectiveness...
Low-Dose Tirzepatide Improves Metabolic Health in Psoriasis and Obesity, suggests study Written By Jacinthlyn Sylvia18 Jun 2026 10:15 PM ISTA new study published in the journal of Dermatology and Therapy showed that treatment with low-dose tirzepatide was linked to clinically significant...
Combined Tirzepatide and Ixekizumab Therapy Shows Dual Benefits in Psoriasis: JAMA Written By Medha Baranwal17 May 2026 9:15 PM ISTUSA: A clinical trial has found that combining tirzepatide with ixekizumab led to significant improvements in skin clearance and weight reduction in...
